Search
for
Sort by
Research 211–240 of 278
- UV Protection Habits and Preferences in Patients With Distinct Cutaneous Immune‐Mediated Inflammatory Diseases
- Modulating the Gut–Skin Axis in Dermatological Diseases: Mechanisms and Clinical Applications of Probiotics, Prebiotics, Synbiotics, and Postbiotics
- Tacrolimus ointment: summarizing two decades of experience in off-label use. Use in rosacea, seborrheic dermatitis, papulosquamous dermatoses, lupus erythematosus, eczematous dermatoses, alopecia, and other diseases
- Insulin Resistance, Metabolic Syndrome, and Inflammatory Skin Disease
- Inflammatory Skin Disease in Latin America: Treatment Challenges and Opportunities
- Utilization of Stem Cells in Medicine: A Narrative Review
- Unique Circulating MicroRNA Signatures Distinguish Severe Alopecia Areata from Other Inflammatory Skin Diseases
- Precision Dermatology: A Review of Molecular Biomarkers and Personalized Therapies
- Hydrobiome of Thermal Waters: Potential Use in Dermocosmetics
- The brain–gut–skin axis in inflammatory and disfiguring skin diseases: mechanistic insights, clinical correlations, and therapeutic strategies
- The imbalance between Type 17 T-cells and regulatory immune cell subsets in psoriasis vulgaris
- Recent Advances in the Use of Cubosomes as Drug Carriers with Special Emphasis on Topical Applications
- Topical and transdermal lipid-polymer hybrid nanoparticles (LPN): an integration in advancing dermatological treatments
- Human Regulatory T Cells: Understanding the Role of Tregs in Select Autoimmune Skin Diseases and Post-Transplant Nonmelanoma Skin Cancers
- 42175 PASI improvement in the first 12 weeks from the Phase 3 VOYAGE 1, VOYAGE 2, ORION and ECLIPSE guselkumab clinical trials
- Generalized hypertrichosis due to secukinumab in a patient with moderate psoriasis: A case of serendipity or zemblanity?
- Immune signatures of psoriasis: Comparison of genetic expression profiles in psoriasis patients after therapy with biologic agents
- Journal Club: A review of topical and intralesional therapeutics for different types of alopecia
- Efficacy and Safety of Biologic Therapies for Treatment of Psoriasis: A Systematic Review and Observational Meta-Analysis
- Integrating systemic agents in clinic-based practice
- A multifunctional bilayer wound dressing co-loaded with nanosilver and bFGF for enhanced skin regeneration: synergistic antibacterial, hemostatic, and angiogenic effects
- Emerging smart microneedle technologies in psoriasis: convergence of nanocarriers, machine learning, and personalized delivery
- Successful Treatment of Refractory Alopecia Areata Universalis and Psoriatic Arthritis, But Not of Plaque Psoriasis with Tofacitinib in a Young Woman
- Generalized hypertrichosis associated with the use of interleukin 17 blockers in 2 patients with psoriasis
- Compounded topical preparations in plaque psoriasis: Still a place for it in 2018?
- The Editor's Choice
- Skin manifestations of obesity: a comparative study
- Psoriasis patients demonstrate HLA-Cw*06:02 allele dosage-dependent T cell proliferation when treated with hair follicle-derived keratin 17 protein
- The Association Between Low Grade Systemic Inflammation and Skin Diseases: A Cross-sectional Survey in the Northern Finland Birth Cohort 1966
- The dermatological consequences of obesity